Notice2024-02505
Notice of Award of a Sole Source Cooperative Agreement To Fund Namibia Ministry of Health and Social Services (MOHSS), Rwanda Biomedical Center, South African Medical Research Council, South African National AIDS Council Trust (SANAC), Tanzania Commission for AIDS (TACAIDS), President's Office-Regional Administration and Local Government (PO-RALG), and Vietnam Administration for HIV/AIDS Control (VAAC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 7, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award(s) of approximately $8,000,000 for Year 1 funding to MOHSS, $4,000,000 for Year 1 funding to Rwanda Biomedical Center, $3,000,000 for Year 1 funding to South African Medical Research Council, $3,000,000 for Year 1 funding to SANAC, $500,000 for Year 1 funding to TACAIDS, $500,000 for Year 1 funding to PO-RALG, and $6,000,000 for Year 1 funding to VAAC. The(se) award(s) will strengthen comprehensive and integrated service delivery for prevention, implement strategies and activities that strengthen local entities, support the coordination, management, and monitoring of multi-sectoral implementation, foster the government's capacity to provide comprehensive management of the HIV program, and implement a sustainable and quality-assured HIV diagnostic, testing, and health information management program in Namibia, Rwanda, South Africa, Tanzania, and Vietnam. Funding amounts for years 2-5 will be set at continuation.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 26 (Wednesday, February 7, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 26 (Wednesday, February 7, 2024)]
[Notices]
[Pages 8432-8433]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-02505]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Sole Source Cooperative Agreement To Fund
Namibia Ministry of Health and Social Services (MOHSS), Rwanda
Biomedical Center, South African Medical Research Council, South
African National AIDS Council Trust (SANAC), Tanzania Commission for
AIDS (TACAIDS), President's Office--Regional Administration and Local
Government (PO-RALG), and Vietnam Administration for HIV/AIDS Control
(VAAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award(s) of approximately $8,000,000 for Year 1 funding to MOHSS,
$4,000,000 for Year 1 funding to Rwanda Biomedical Center, $3,000,000
for Year 1 funding to South African Medical Research Council,
$3,000,000 for Year 1 funding to SANAC, $500,000 for Year 1 funding to
TACAIDS, $500,000 for Year 1 funding to PO-RALG, and $6,000,000 for
Year 1 funding to VAAC. The(se) award(s) will strengthen comprehensive
and integrated service delivery for prevention, implement strategies
and activities that strengthen local entities, support the
coordination, management, and monitoring of multi-sectoral
implementation, foster the government's capacity to provide
comprehensive management of the HIV program, and implement a
sustainable and quality-assured HIV diagnostic, testing, and health
information management program in Namibia, Rwanda, South Africa,
Tanzania, and Vietnam. Funding amounts for years 2-5 will be set at
continuation.
DATES: The period for these award will be September 30, 2024, through
September 29, 2029.
FOR FURTHER INFORMATION CONTACT: Benjamin Monroe, Center for Global
Health, Centers for Disease Control and Prevention, CDC Namibia,
Private Bag 12029, Ausspannplatz, Windhoek, Namibia, Telephone:
404.639.1523, Email: <a href="/cdn-cgi/l/email-protection#7e17161a4c3e1d1a1d50191108"><span class="__cf_email__" data-cfemail="d4bdbcb0e694b7b0b7fab3bba2">[email protected]</span></a>.
Antyme Kayisabe, Center for Global Health, Centers for Disease
Control and Prevention, US Embassy Kigali; 30KG 7 Avenue (Kacyiru);
P.O. Box 28 Kigali, Rwanda, Telephone: 788.382.114, Email:
<a href="/cdn-cgi/l/email-protection#4028313179002324236e272f36"><span class="__cf_email__" data-cfemail="4c243d3d750c2f282f622b233a">[email protected]</span></a>.
Rehmeth Fakroodeen, Center for Global Health, Centers for Disease
Control and Prevention, 100 Totius Street, Groenkloof, Pretoria,0181,
Telephone: 278.252.43786, Email: <a href="/cdn-cgi/l/email-protection#addad7db9dedcec9ce83cac2db"><span class="__cf_email__" data-cfemail="06717c70364665626528616970">[email protected]</span></a>.
Rachael Joseph, Center for Global Health, Centers for Disease
Control and Prevention, 100 Totius Street, Groenkloof, Pretoria,0181,
Telephone: 27 822544430, Email: <a href="/cdn-cgi/l/email-protection#05736c6030456661662b626a73"><span class="__cf_email__" data-cfemail="780e111d4d381b1c1b561f170e">[email protected]</span></a>.
Angela Schaad, Center for Global Health, Centers for Disease
Control and Prevention, 2448 Luthuli Road Dar Es Salaam Tanzania,
Telephone: 404.718.3639, Email: <a href="/cdn-cgi/l/email-protection#563d3f38611635323578313920"><span class="__cf_email__" data-cfemail="4d2624237a0d2e292e632a223b">[email protected]</span></a>.
Amy Bailey, Center for Global Health, Centers for Disease Control
and Prevention, 5th/Floor Tung Shing Building, No 2, Ngo Quyen Street,
Hoan Kiem District Hanoi, Vietnam, Telephone: 011842439352692, Email:
<a href="/cdn-cgi/l/email-protection#dcbaa9b9e49cbfb8bff2bbb3aa"><span class="__cf_email__" data-cfemail="a6c0d3c39ee6c5c2c588c1c9d0">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The(se) sole source award(s) will maintain
HIV and achieve TB epidemic control and strengthen public health
systems and security, implement evidence-based decision-making,
technical leadership, and coordination of quality HIV prevention and
care and treatment (C&T) services, strengthen systems and processes at
multiple health system levels, support coordination and implementation
of United States Government (USG)-funded public health activities, and
ensure the quality of HIV diagnostics and testing, track the quality of
services to persons living with HIV (PLHIV) on treatment, and monitor
the cascade progression to HIV epidemic control in Namibia, Rwanda,
South Africa, Tanzania, and Vietnam.
MOHSS is in a unique position to conduct this work, as it is the
sole government entity charged with the operation of Namibia's public
healthcare system. It is the only body authorized by law to develop and
implement health policies in the public health sector, and to enforce
national health laws in the public and private healthcare sectors. As
the government ministry with exclusive authority over the healthcare
system, it is the only organization in Namibia eligible to receive
direct government-to-government support for the HIV/AIDS activities
proposed by CDC.
Rwanda Biomedical Center is in a unique position to conduct this
work, as it develops policies and regulations for medical laboratories,
conducts specialized testing, monitors the performance and operation of
other
[[Page 8433]]
laboratories in Rwanda, and establishes relations and collaborations
with other national and international agencies carrying out similar
responsibilities. No other agency in the public or private sector
performs this responsibility.
South African Medical Research Council is in a unique position to
conduct this work, as it is a government body responsible for
biomedical research of national importance and is the only agency with
this direct governmental mandate in South Africa.
SANAC is in a unique position to conduct this work, as it is
mandated to coordinate a truly multi-sectoral response to the epidemics
at a national and sub-national level. Therefore, SANAC is authorized to
collaborate with government departments, the private health sector,
other development partners, and non-governmental organizations (NGOS)
to develop strategies to reach epidemic control.
TACAIDS is in a unique position to conduct this work, as it has
sole legal authority to provide strategic multi-sectorial leadership
and to coordinate and strengthen efforts of all stakeholders involved
in the national HIV/AIDS response. TACAIDS has 16 functions to aid in
achieving their mandate.
PO-RALG is in a unique position to conduct this work, as it is
legally the only government agency that interprets national policies,
strategies, and guidelines related to health and social welfare sector
development, financing, and human resources; provides supportive
supervision and mentorship to RAs and LGAs; and ensures implementation
of policies and regulations by RAs and LGAs. PO-RALG has oversight and
management of all dispensaries, health facilities, and regional
hospitals, as well as all health care workers.
VAAC is in a unique position to conduct this work, as it uniquely
qualified for this funding opportunity because of their political
mandate, clearly acknowledged leadership by all partners, and
significant experience to continue a strong and vital coordinating role
for HIV programs.
Summary of the award:
Recipient: Namibia Ministry of Health and Social Services (MOHSS),
Rwanda Biomedical Center, South African Medical Research Council, South
African National AIDS Council Trust (SANAC), Tanzania Commission for
AIDS (TACAIDS), President's Office--Regional Administration and Local
Government (PO-RALG), and Vietnam Administration for HIV/AIDS Control
(VAAC).
Purpose of the Award: The purpose of these awards is to strengthen
comprehensive and integrated service delivery for prevention and
implement strategies and activities that strengthen local entities,
support the coordination, management, and monitoring of multi-sectoral
implementation, foster the government's capacity to provide
comprehensive management of the HIV program, and implement a
sustainable and quality-assured HIV diagnostic, testing, and health
information management program in Namibia, Rwanda, South Africa,
Tanzania, and Vietnam.
Amount of Award: For MOHSS, the approximate year 1 funding amount
will be $8,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Amount of Award: For Rwanda Biomedical Center, the approximate year
1 funding amount will be $4,000,000 in Federal Fiscal Year (FYY) 2024
funds, subject to the availability of funds. Funding amounts for years
2-5 will be set at continuation.
Amount of Award: For South African Medical Research Council, the
approximate year 1 funding amount will be $(3,000,000 in Federal Fiscal
Year (FYY) 2024 funds, subject to the availability of funds. Funding
amounts for years 2-5 will be set at continuation.
Amount of Award: For SANAC, the approximate year 1 funding amount
will be $3,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Amount of Award: For TACAIDS, the approximate year 1 funding amount
will be $500,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Amount of Award: For PO-RALG, the approximate year 1 funding amount
will be $500,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds.
Amount of Award: For VAAC, the approximate year 1 funding amount
will be $6,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: These programs are authorized under Public Law 108-25
(the United States Leadership Against HIV AIDS, Tuberculosis and
Malaria Act of 2003) [22 U.S.C. 7601, et seq.] and Public Law 110-293
(the Tom Lantos and Henry J. Hyde United States Global Leadership
Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of
2008), and Public Law 113-56 (PEPFAR Stewardship and Oversight Act of
2013).
Period of Performance: The period for these awards will be
September 30, 2024, through September 29, 2029.
Dated: January 24, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Acting Chief Grants
Management Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02505 Filed 2-6-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 7, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.